Achilles Therapeutics (ACHL) Q1 2023 Earnings

May 10Confirmed
Aug 2022
Nov 2022
Q4 2022
Q1 2023
-0.61
-0.51
-0.42
-0.32

Details

Expected EPS
-0.4
Actual EPS
-0.44
Surprise EPS
-0.04
Surprise Percent
-10%

Description

⁨Achilles Therapeutics⁩ (⁦ACHL⁩) has reported earnings of ⁦-0.44⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts